Ousia Pharma

Zealand Pharma

This biotechnology company develops peptide-based medicines for patients with obesity, rare diseases and chronic inflammation through metabolic health research.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

Prolynx

The company develops long-acting medicines for obesity and metabolic conditions using proprietary drug delivery technology for patients requiring less frequent dosing.

Hawkhill Therapeutics

This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.

Metsera

The company develops injectable and oral medicines for patients with obesity and metabolic diseases.

Alveus Therapeutics

This clinical-stage biotechnology company develops next-generation therapies for obesity and metabolic diseases to provide sustained weight loss for patients.

Fable Therapeutics

The company develops protein-engineered biologics using machine learning to treat patients with obesity and metabolic diseases.